Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 8
Submit an article Journal homepage
640
Views
11
CrossRef citations to date
0
Altmetric
Research Article

5-Azacitidine efficacy and safety in patients aged >65 years with myelodysplastic syndromes outside clinical trials

Massimo BrecciaDepartment of Cellular Biotechnologies and Hematology, Sapienza University, Rome, ItalyCorrespondence[email protected]
,
Giuseppina LoglisciDepartment of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
,
Adriano SalaroliDepartment of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
,
Alessandra SerraoDepartment of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
,
Luigi PetrucciDepartment of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
,
Marco ManciniDepartment of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
&
Giuliana AlimenaDepartment of Cellular Biotechnologies and Hematology, Sapienza University, Rome, Italy
 show all
Pages 1558-1560 | Received 03 Jan 2012, Accepted 20 Jan 2012, Published online: 21 Feb 2012

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Massimo Breccia, Matteo Molica, Irene Zacheo & Giuliana Alimena. (2014) Azacitidine for myelodysplastic patients aged > 65 years: a review of clinical efficacy. Expert Opinion on Pharmacotherapy 15:11, pages 1621-1630.
Read now
Blanca Xicoy, María-José Jiménez, Olga García, Joan Bargay, Violeta Martínez-Robles, Salut Brunet, María-Jesús Arilla, Jaime Pérez de Oteyza, Rafael Andreu, Francisco-Javier Casaño, Carlos-Javier Cervero, Alicia Bailén, María Díez, Bernardo González, Ana-Isabel Vicente, Carme Pedro, Teresa Bernal, Elisa Luño, María-Teresa Cedena, Luis Palomera, Adriana Simiele, José-Manuel Calvo, Víctor Marco, Eduardo Gómez, Marta Gómez, David Gallardo, Juan Muñoz, Raquel de Paz, Javier Grau, Josep-Maria Ribera, Luis-Enrique Benlloch & Guillermo Sanz. (2014) Results of treatment with azacitidine in patients aged ≥ 75 years included in the Spanish Registry of Myelodysplastic Syndromes. Leukemia & Lymphoma 55:6, pages 1300-1303.
Read now

Articles from other publishers (9)

Carmelo Gurnari, Zhuoer Xie & Amer M. Zeidan. (2022) How I Manage Transplant Ineligible Patients with Myelodysplastic Neoplasms. Clinical Hematology International 5:1, pages 8-20.
Crossref
Rory M. Shallis & Amer M. Zeidan. (2018) More is less, less is more, or does it really matter? The curious case of impact of azacitidine administration schedules on outcomes in patients with myelodysplastic syndromes. BMC Hematology 18:1.
Crossref
Roman M. Shapiro & Alejandro Lazo-Langner. (2018) Systematic review of azacitidine regimens in myelodysplastic syndrome and acute myeloid leukemia. BMC Hematology 18:1.
Crossref
Yang Lv, Bo Liu, Yuan Liu, Haoyu Wang & Haiping Wang. (2018) TGF‑β1 combined with Sal‑B promotes cardiomyocyte differentiation of rat mesenchymal stem cells. Experimental and Therapeutic Medicine.
Crossref
Yang Lv, Chen-Wei Gao, Bo Liu, Hao-Yu Wang & Hai-Ping Wang. (2017) BMP-2 combined with salvianolic acid B promotes cardiomyocyte differentiation of rat bone marrow mesenchymal stem cells. The Kaohsiung Journal of Medical Sciences 33:10, pages 477-485.
Crossref
Y. Lv, B. Liu, H.P. Wang & L. Zhang. (2016) Intramyocardial implantation of differentiated rat bone marrow mesenchymal stem cells enhanced by TGF-β1 improves cardiac function in heart failure rats. Brazilian Journal of Medical and Biological Research 49:6.
Crossref
Sally B. Killick, Chris Carter, Dominic Culligan, Christopher Dalley, Emma Das-Gupta, Mark Drummond, Helen Enright, Gail L. Jones, Jonathan Kell, Juliet Mills, Ghulam Mufti, Jane Parker, Kavita Raj, Alexander Sternberg, Paresh Vyas & David Bowen. (2014) Guidelines for the diagnosis and management of adult myelodysplastic syndromes. British Journal of Haematology 164:4, pages 503-525.
Crossref
Massimo Breccia, Adriano Salaroli, Alessandra Serrao & Giuliana Alimena. (2013) Azacitidine as salvage therapy in elderly patients with relapsed acute myeloid leukemia after autologous transplantation. Annals of Hematology 92:10, pages 1413-1414.
Crossref
Drorit Merkel, Kalman Filanovsky, Anat Gafter‐Gvili, Liat Vidal, Ariel Aviv, Moshe E. Gatt, Itay Silbershatz, Yair Herishanu, Ariela Arad, Tamar Tadmor, Najib Dally, Anatoly Nemets, Ory Rouvio, Aharon Ronson, Katrin Herzog‐Tzarfati, Luiza Akria, Andrei Braester, Ilana Hellmann, Shay Yeganeh, Arnon Nagler, Ronit Leiba, Moshe Mittelman & Yishai Ofran. (2013) Predicting infections in high‐risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study. American Journal of Hematology 88:2, pages 130-134.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.